Document:

Exhibit 10.8

 

INDEMNITY AGREEMENT

 

This Agreement has been entered into as of the        day
of        .

 

BETWEEN:

 

ONCOGENEX TECHNOLOGIES INC., a corporation
incorporated under the laws of Canada and having an office at D-9 2733 Heather
Street, Vancouver, British Columbia, V5Z 3J5, Facsimile No. (604) 875-5604

 

(the “Indemnitor”)

 

AND:

 

	
   

  	
   

  	
   

  
	
  (the “Indemnitee”)

  

 

WHEREAS: The Indemnitor has requested the Indemnitee to
act as a director of the Indemnitor and may request the Indemnitee, from time
to time, to act as a director of another entity at the Indemnitor’s request,
and the Indemnitee has agreed, subject to the granting of the indemnities
herein provided for, to act in the aforementioned capacities;

 

NOW THEREFORE in consideration of these premises, the mutual
covenants and agreements herein contained and other good and valuable
consideration, the receipt and sufficiency of which is acknowledged by each of
the parties hereto, the parties hereto covenant and agree as set forth below.

 

ARTICLE 1 - INDEMNITY

 

1.1           Scope of Indemnity - Subject to
subsections 1.2, 1.7, 1.8, 2.7 and 2.8 below, the Indemnitor shall to the
fullest extent possible under applicable law indemnify and save harmless the
Indemnitee against and from:

 

(a)                                  any and all charges and
claims of every nature and kind whatsoever which may be brought or made by any
person, firm, corporation or government, or by any governmental department,
body, commission, board, bureau, agency or instrumentality against the
Indemnitee in connection with the execution of the duties of his office as a
director or by virtue of his holding any other directorship with any other
entity held by the Indemnitee at the Indemnitor’s request;

 

(b)                                 any and all costs,
damages, expenses (including legal fees and disbursements on a full indemnity
basis), fines, liabilities (statutory or otherwise), losses and penalties which
the. Indemnitee may sustain, incur or be liable for in consequence of his
acting as a director of the Indemnitor, whether sustained or incurred by reason
of his negligence, default, breach of duty, breach of trust, failure to
exercise due diligence or otherwise in relation to the Indemnitor or any of its
affairs; and

 

 

(c)                                  in particular, and
without in any way limiting the generality of the foregoing, any and all costs,
damages, expenses (including legal fees and disbursements on a full indemnity
basis), fines, liabilities, losses and penalties which the Indemnitee may
sustain, incur or be liable for as a result of or in connection with the
release of or presence in the environment of substances, contaminants, litter,
waste, effluent, refuse, pollutants or deleterious materials and that arise out
of or are in any way connected with the management, operation, activities or
existence of the Indemnitor or by virtue of the Indemnitee holding any other
directorship with any other entity held by the Indemnitee at the Indemnitor’s
request.

 

1.2           Indemnity Restricted - If, under
applicable law, any payment by the Indemnitor under section 1.1 first requires
the approval of any court, the Indemnitor, at its own expense and in good
faith, will promptly take all necessary proceedings to obtain such approval.

 

1.3           Taxable Benefits - The Indemnitor
shall gross up any indemnity payment made pursuant to this Indemnity Agreement
by the amount of any income tax payable by the Indemnitee in respect of that
payment.

 

1.4           Enforcement Costs - The Indemnitor
shall indemnify the Indemnitee for the amount of all costs incurred by the
Indemnitee in obtaining any court approval required to enable or require the
Indemnitee to make a payment under or in enforcing this Indemnity Agreement,
including without limitation legal fees and disbursements on a full indemnity
basis.

 

1.5           Re-Election - The obligations of
the Indemnitor under this Indemnity Agreement continue after and are not
affected in any way by the re-election or re-appointment from time to time of
the Indemnitee as a director of the Indemnitor or of any entity in which he
holds a directorship at the request of the Indemnitor.

 

1.6           Nominee’s Compensation - The
obligations of the Indemnitor under this Indemnity Agreement are not diminished
or in any way affected by:

 

(a)                                  the Indemnitee holding
from time to time any direct or indirect financial interest in the Indemnitor
or in any entity in which he holds such directorship at the request of the
Indemnitor;

 

(b)                                 payment to the Indemnitee
by the Indemnitor of director’s fees or any salary, wages, or any other form of
compensation or remuneration or in any entity which he holds such directorship
at the request of the Indemnitor; and.

 

(c)                                  except as otherwise
herein provided, any directors’ liability insurance placed by or for the
benefit of the Indemnitee by the Indemnitee, the Indemnitor or any entity in
which the Indemnitee holds a directorship at the request of the Indemnitor.

 

1.7           Limitation on Indemnitee - Notwithstanding
the provisions of subsection 1.1, the Indemnitor shall not be obligated to
indemnify or save harmless the Indemnitee against and from any charge, claim,
cost, damage, expense, fine, liability, loss or penalty if a court of competent
jurisdiction finds that:

 

2

 

(a)           the
Indemnitee failed to act honestly and in good faith with a view to the best
interest of:

 

(i)                                     the Indemnitor, if the
claim relates to his position as a director of the Indemnitor, or

 

(ii)                                  the entity with which the
Indemnitee holds or held a directorship at the Indemnitor’s request;

 

(b)                                 in the case of a criminal
or administrative action or proceeding that is enforced by a monetary penalty,
the Indemnitee did not have reasonable grounds for believing that his conduct
was lawful; or

 

(c)                                  in the case of any act,
error or omission of the Indemnitee, the Indemnitee acted fraudulently or
maliciously.

 

1.8           Insurance Limitation - Notwithstanding
the provisions of subsections 1.1 and 1.6, the Indemnitor shall have no
obligation to indemnify or save harmless the Indemnitee in respect of any
liability for which the Indemnitee is entitled to indemnity pursuant to any
valid and collectible policy of insurance obtained and maintained by the
Indemnitor, to the extent of the amounts actually collected by the Indemnitee
under such insurance policy. Where partial indemnity is provided by such
insurance policy, the obligation of the Indemnitor under subsection 1.1 shall
continue in effect but be limited to that portion of the liability for which
indemnity is not provided by such insurance policy.

 

ARTICLE 2 - DEFENCE

 

2.1           Interpretation - For the purposes
of section 2:

 

“Action” means any action,
inquiry, investigation, suit or other proceeding before a court or other
tribunal in which a Claim is brought, made or advanced by or against the
Indemnitee;

 

“Claim” means any charge, claim,
cost, damage, expense, fine, liability, loss or penalty contemplated by
subsection 1.1;.

 

“Judgment” means an award of damages
or other monetary compensation made in an Action or any amounts the Indemnitee
is ordered to pay by any court or other tribunal or any government,
governmental department, body, commission, board, bureau, agency or
instrumentality having proper jurisdiction as a result of any Claim brought,
made or advanced by or against the Indemnitee; and

 

“Settlement” means an agreement to
compromise a Claim or an Action.

 

2.2           Notice of Claim - Upon the
Indemnitee or the Indemnitor becoming aware of any pending or threatened Claim
or Action, written notice shall be given by or on behalf of one to the other as
soon as is reasonably practicable.

 

3

 

2.3           Right to Conduct Investigation - The
Indemnitor shall conduct such investigation of each Claim as is reasonably
necessary in the circumstances and shall pay all costs of such investigation.

 

2.4           Defence of Claim - Subject to this
subsection and subsection 2.7, the Indemnitor shall defend, on behalf of the
Indemnitee, any Action, even if the Claim upon which the Action is founded is
groundless, false or fraudulent.

 

2.5           Appointment of Counsel - The
Indemnitor shall consult with and pay reasonable heed to the Indemnitee
concerning the appointment of any defence counsel to be engaged by the
Indemnitor in fulfilment of its obligation to defend an Action pursuant to
subsection 2.4; thereafter the Indemnitor shall appoint counsel.

 

2.6           Settlement Negotiations - With
respect to a Claim for which the Indemnitor is obliged to indemnify the
Indemnitee hereunder, the Indemnitor may conduct negotiations towards a
Settlement and, with the written consent of the Indemnitee (which the
Indemnitee agrees not to unreasonably withhold), the Indemnitor may make such
Settlement as it deems expedient provided, however, that the Indemnitee shall
not be required, as part of any proposed Settlement, to admit liability or
agree to indemnify the Indemnitor in respect of, or make contribution to, any
compensation or other payment for which provision is made by such Settlement.

 

2.7           Failure to Consent to Settlement - With
respect to a Claim for which the Indemnitor is obliged to indemnify the
Indemnitee hereunder, if the Indemnitee fails to give his consent to the terms
of a proposed Settlement which is otherwise acceptable to the Indemnitor and
the claimant, the Indemnitor may require the Indemnitee to negotiate or defend
the Action independently of the Indemnitor and in such event any amount
recovered by such claimant in excess of the amount for which Settlement could
have been made by the Indemnitor, shall not be recoverable under this
Indemnity, it being further agreed by the parties that the Indemnitor shall
only be responsible for legal fees and costs up to the time at which such
Settlement could have been made.

 

2.8           Settlement in Certain Circumstances  -
The Indemnitor, in consultation with the Indemnitee, shall have the right to
negotiate a Settlement in respect of any Claim or Action which is founded upon
any of the acts specified in subsection 1.7. In the event that the Indemnitor
negotiates such a Settlement, the Indemnitee shall pay any compensation or
other payment for which provision is made under the Settlement and shall not seek
indemnity or contribution from the Indemnitor in respect of such compensation
or payment. The Indemnitee shall pay to the Indemnitor, within 60 days of the
Indemnitor making demand therefor, all fees, costs and expenses (including
legal fees and disbursements on a full indemnity basis) which result from the
defence of the Claim or the Action in respect of which the Settlement was made.

 

2.9           Payment of Judgment - The
Indemnitor shall pay any Judgment which may be given against the Indemnitee
unless any of the circumstances in subsection 1.7 applies to the Action in
respect of which the Judgment is given or unless and to the extent the
Indemnitee is otherwise entitled to indemnity under the policy of insurance as
contemplated by subsection 1.8 in either case, the Indemnitee shall pay to the
Indemnitor, within 60 days of the Indemnitor making demand therefor, all fees,
costs and expenses (including legal fees and disbursements on a full 

 

4

 

indemnity basis) which result from the defence and
appeal of the Action, including the costs of any investigation undertaken by
the Indemnitor in connection with the Action.

 

ARTICLE 3 - GENERAL

 

3.1           Nothing
herein contained shall in any way affect the Indemnitee’s right to resign from
his position as a director of the Indemnitor or at any time to resign from his
position with any other entity held at the Indemnitor’s request at any time.

 

3.2           The
indemnity herein provided for shall survive the termination of the Indemnitee’s
position as a director of the Indemnitor and the termination of any
directorship held by the Indemnitee at the Indemnitor’s request, whether by
resignation, removal, death, incapacity, disqualification under applicable law,
or otherwise, and shall continue in full force and effect thereafter.

 

3.3           Unless
stated otherwise, all monies to be paid hereunder shall be paid within 10 days
of becoming payable.

 

3.4           If
any provision of this agreement is determined to be invalid or unenforceable in
whole or in part, such invalidity or unenforceability shall attach only to such
provision or part thereof and the remaining part of such provision and all
other provisions hereof shall continue in full force and effect. The parties
hereto agree to negotiate in good faith to agree to a substitute provision
which shall be as close as possible to the intention of any invalid or
unenforceable provision as may be valid or enforceable. The invalidity or
unenforceability of any provision in any particular jurisdiction shall not affect
its validity or enforceability in any other jurisdiction where it is valid or
enforceable.

 

3.5           Each
party hereto agrees to do all such things and take all such actions as may be
necessary or desirable to give full force and effect to the matters contemplated
by this agreement.

 

3.6           This
agreement shall enure to the benefit of and be binding upon the parties hereto
and their respective heirs, executors, administrators, legal representatives,
successors and permitted assigns.

 

3.7           Time
shall be of the essence of this agreement.

 

3.8           This
Agreement shall be exclusively construed and governed by the laws in force in
British Columbia and the laws of Canada applicable therein, and, except as
provided in Section 3.9, the courts of British Columbia (and Supreme Court of
Canada, if necessary) shall have exclusive jurisdiction to hear and determine
all disputes arising hereunder. Subject to Section 3.9, each of the parties
hereto irrevocably attorns to the jurisdiction of said courts and consents to
the commencement of proceedings in such courts. This Section shall not be
construed to affect the rights of a party to enforce a judgment or award
outside said province, including the right to record and enforce a judgment or
award in any other jurisdiction.

 

5

 

3.9           In
the event of a dispute which does not involve a party seeking a court
injunction or a determination referred to in section 1.7, that dispute shall be
resolved between the Indemnitor and the Indemnitee in respect of the indemnity
provided by this Agreement by arbitration subject to the provisions of the Commercial Arbitration Act, R.S.B.C. 1996 c. 55 as amended
from time to time. The arbitrated resolution of the dispute shall be final and
binding on all parties. The place of arbitration will be Vancouver, British
Columbia.

 

IN WITNESS WHEREOF the parties hereto have signed, sealed and
delivered this agreement as of the date first written above.

 

ONCOGENEX TECHNOLOGIES INC.

 

 

	
  Per:

  	
  /s/ Scott Cormack

  	
   

  
	
   

  	
  (Authorized
  Signatory)

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  

 

6Exhibit 10.9

 

CONSULTING AGREEMENT

 

THIS
AGREEMENT executed as of the 15th day of February, 2005 (the “Effective Date”)

 

BETWEEN:

 

CANAID, Inc., an independent
contractor with the address of P.O. Box 1005, Hanalei, Hawaii, 96714
(hereinafter referred to as “Consultant”)

 

- and -

 

OncoGeneX
Technologies Inc., a corporation incorporated pursuant to the
laws of the Canada with offices situated at Suite 400, 1001 West Broadway, Vancouver, British
Columbia V6H 4B1 (hereinafter referred to as the “Client”)

 

WITNESS WHEREAS the Client is a biotechnology company engaged in the
development of therapeutics and diagnostics for cancer,

 

AND WHEREAS the Consultant is
engaged in the provision of advisory services related to clinical trials,

 

AND WHEREAS the Client desires
to engage the Consultant to provide the Advisory Services (as defined below)
and the Consultant has agreed to provide the same on the terms and conditions
contained herein.

 

NOW THEREFORE in consideration of
the mutual covenants contained herein, the parties hereto agree as follows:

 

ARTICLE I - ADVISORY SERVICES

 

1.1                           The Client
hereby engages the Consultant as an independent contractor and the Consultant
agrees to provide the Client advisory services in connection with the Client’s
Business, including but not limited to the provision of advice and counsel on
the design, implementation and analysis of clinical trials (the “Advisory Services”). For the purposes of this Agreement, “Business” means the development and commercialization of the
Company Technology (as defined in Section 6.1 hereof) and such other business
plans as approved by the Client’s board of directors from time to time and
which are in effect on the date of termination of this Agreement.

 

1.2                           The Client
from time to time during the currency of this Agreement shall specify those
specific areas of activity in which it desires Advisory Services to be
provided.

 

1.3                           The
Consultant shall provide its own work methods and equipment for performing the
Advisory Services.

 

1.4                           The
Consultant shall perform the Advisory Services in accordance with industry
standards and high standards of ethics.

 

 

Consulting
Agreement – OncoGenex / Canaid Inc.

 

1

 

ARTICLE 2 - TERM

 

2.1                           The term (“Term”) of this Agreement shall commence on the Effective
Date and continue until the first anniversary thereof, unless extended and
amended as appropriate by both parties in writing prior to the end of the Term.
Notwithstanding the foregoing, this contract may be terminated by either party
on thirty (30) days prior written notice, or in accordance with the terms
otherwise contained herein.

 

ARTICLE 3 - COMPENSATION AND EXPENSES

 

3.1                           For the
provision of the Advisory Services herein, the Client shall pay to the
Consultant work fees (the “Work Fees”)
payable at an hourly rate of US$200 and a per diem rate of US$2,000, to be
submitted by way of invoice after service has been performed and due within ten
(10) days of receipt of the same.

 

3.2                           The
Consultant will provide the number of hours reasonably necessary to perform the
Advisory Services contemplated under this Agreement. The Client and the
Consultant understand that the hours of work required to perform those duties
will be irregular.

 

3.3                           The Client shall reimburse the Consultant for all reasonable expenses
incurred by it on behalf of the Client, provided that any expenses related to
out-of-town travel are approved in advance by the Client. The Client shall make
reimbursement payments as soon as reasonably practicable after receiving a
statement setting forth expenses incurred and related receipts and in any event
within ten (10) days after the Client’s receipt of such supporting
documentation.

 

ARTICLE 4 - CONFIDENTIALITY & EXCLUSIVITY

 

4.1                           It is
acknowledged and agreed by the parties hereto that the Advisory Services to be
provided hereunder by the Consultant to the Client are subject to the
confidentiality provisions of this Article 4 and are to be provided on a non-exclusive
basis. It is acknowledged by the Client that the Consultant may be providing
substantially similar services to other persons, and the Client acknowledges
that the obligations hereunder shall not prevent or restrict the provision by
the Consultant of such similar services provided only that (i) the Consultant
applies reasonable commercial efforts to its performance hereunder and (ii) the
Consultant does not perform substantially similar services for other companies
during the term of this Agreement that would create a conflict of interest for
the Consultant, or create a conflict between the Client and such other company,
without the prior written consent of the Client such consent not to be
unreasonably withheld.

 

4.2                           The Consultant hereby acknowledges that
by virtue of performing the Advisory Services for the Client, it will have
access to and will be entrusted with Confidential Information, the disclosure
of which may be detrimental to the best interests of the Client. The term “Confidential Information” as used in this Agreement means
all trade secrets, proprietary information and other data or information (and
any tangible evidence, record or representation thereof), whether prepared,
conceived or developed by an employee or consultant of the Client or received
by the Client from an outside source which is maintained in confidence by the
Client or from any of its customers to obtain a competitive advantage over
competitors who do not have access to such trade secrets, proprietary
information, or other data or information. Without limiting the generality of
the foregoing, Confidential Information includes:

 

2

 

(a)           any ideas,
improvements, know-how, research, inventions, innovations, products, services,
sales, scientific or other formulae, processes, methods, machines,
manufactures, compositions, procedures, tests, treatments, developments,
technical data, designs, devices, patterns, concepts, computer programs,
computer code, creative development, training or service manuals, plans for new
or revised services or products or other plans, items or strategy methods on
compilation of information, or works in process that relate to the Business, or
that result from its marketing, research and/or development activities;

 

(b)           any information
relating to the relationship of the Client with any clients, customers,
suppliers, principals, contacts or prospects of the Client and any information
relating to the requirements, specifications, proposals, orders, contracts or
transactions of or with any such clients, customers, suppliers, principals,
contacts or prospects of the Client, including but not limited to client lists;

 

(c)           any sales plan,
marketing material, plan or survey, business plan or opportunity, product or
service development plan or specification, business proposal or business
agreement; and

 

(d)           any information relating to the present
or proposed Business.

 

4.3                           The Consultant agrees that the
Confidential Information is and will remain the exclusive property of the
Client including any Confidential Information that the Consultant developed or
helped to develop. The Consultant also agrees that the Confidential
Information:

 

(a)           constitutes a
proprietary right which the Client is entitled to protect; and

 

(b)           constitutes
information and knowledge not generally known to the trade.

 

4.4                           The Consultant understands that the
Client has from time to time in its possession information belonging to others
or which is claimed by others to be confidential or proprietary and which the
Client has agreed to keep confidential. The Consultant agrees that all such
information shall be Confidential Information for the purposes of this
Agreement.

 

4.5                           The
Consultant acknowledges and agrees that any Confidential Information disclosed
to the Consultant is in the strictest confidence and the Consultant agrees to
maintain and hold in strict confidence all Confidential Information disclosed
to it. The disclosure of any such Confidential Information by the Consultant in
any form whatsoever except (i) as required in performance of the Advisory
Services hereunder and in furtherance of the best interest of the Client, (ii)
as authorized by the Client including under a non-disclosure agreement signed
by the Client, or (iii) as permitted under Section 4.8 of this Agreement, is
and shall be considered a fundamental breach of this Agreement and shall
entitle the Client to terminate immediately this Agreement without further
payment to the Consultant (except for work performed prior to such breach).

 

4.6                           Except
in accordance with this Article 4, the Consultant shall not:

 

(a)           duplicate, transfer,
disclose or use nor allow any other person to duplicate, transfer or disclose
any of the Confidential Information; or

 

(b)           incorporate, in
whole or in part, within any domestic or foreign patent application that is not
for the benefit of the Client, any proprietary or Confidential Information.

 

3

 

4.7                           The
Consultant will safeguard all Confidential Information to which the Consultant
has access at all times so that it is not exposed to or used by unauthorized
persons, and will exercise at least the same degree of care that it would use
to protect its own confidential information.

 

4.8                           The
restrictive obligations set forth above shall not apply to the disclosure or
use of any Confidential Information which:

 

(a)           is or later becomes
publicly known under circumstances involving no breach of any confidentiality
provisions, including this Agreement by the Consultant, or has been approved
for release by the Client;

 

(b)           is already known to
the Consultant outside its work for the Client under this Agreement, at the
time of receipt of the Confidential Information;

 

(c)           is lawfully made
available to the Consultant by a third party; or

 

(d)           is required by law to
be disclosed but only to the extent of such requirement and the Consultant
shall immediately notify the Client in writing of upon receipt of any request
for such disclosure.

 

4.9                           For purposes of the copyright laws of the
United States of America, to the extent, if any, that such laws are applicable
to any Confidential Information, it shall be considered a work made for hire
and the Client shall be considered the author thereof.

 

4.10                         Immediately following the request of the
Client and in any event immediately upon termination of this Agreement, the
Consultant will deliver to the Client all documents in the Consultant’s
possession or control containing Confidential Information without making or
retaining copies.

 

4.11                         The
term “Personal Information” means information
about an identifiable individual collected or created by the
Client or its consultants in relation
to the services they perform for the Company, but does not include the name, title, business address, or business
telephone number of an employee or consultant of the Client.

 

4.12                         Unless
the law otherwise specifies or the Client otherwise directs in writing, the Consultant
may only collect, create, use and disclose Personal Information that is
necessary for the performance of its consulting obligations, and must not
collect, use or disclose Personal Information about an individual without the
consent of the individual to whom the information relates.

 

4.13                         The
Consultant agrees to protect all Personal Information collected or stored by it
by taking reasonable security measures, in accordance with the sensitivity of
the information in question, to protect it against unauthorized access by any
other party, and from unauthorized collection, use, disclosure, copying,
modification or disposal.

 

4.14                         The
Consultant further agrees to comply with all applicable laws and Client
policies and practices that relate to the collection, use, disclosure, storage
and disposal of Personal Information. A copy of the Client’s Confidentiality
and Privacy Policy is attached as Appendix A.

 

4

 

4.15                         The
Consultant agrees to retain Personal Information until directed by the
Client in writing to dispose of it or
deliver it as specified in the direction.

 

4.16                         The
Consultant agrees to immediately rectify, delete or update
Personal Information on receiving instructions to this effect from the Client.

 

4.17                         The
Consultant is liable for protecting all Personal Information in
its possession or control and for any unauthorized use or disclosure thereof.

 

4.18                         The
obligations of the parties under this Personal Information provision will
survive the termination of the Agreement.

 

ARTICLE 5 - REPORTING

 

5.1                           In respect
of the duties and obligations of the Consultant hereunder, it is agreed that
the Consultant shall keep the Client currently informed of its progress.

 

ARTICLE 6 – INTELLECTUAL
PROPERTY

 

6.1                           As used in this Article 6, the following
words and phrases are defined as follows:

 

(a)           “UBC Licenses”
means the licenses entered into by the University of British Columbia and the
Client effective November 1, 2001 and September 1, 2002 which define the terms
under which the Client has acquired an exclusive license to certain technology.

 

(b)           “Technology”
means all ideas, concepts, business and trade names, trademarks, know-how,
trade secrets, inventions, improvements, devices, methods, processes and
discoveries, whether patentable or not, and whether or not reduced to writing
or other tangible form or to actual or constructive practice which either: (i) are part of the technology licensed to the
Client under the UBC Licenses; or (ii) are otherwise developed or acquired on
behalf of or by the Client.

 

6.2                           The Consultant acknowledges and agrees
that the Client is currently engaged in the development and commercialization
of the Technology. In consideration of the Work Fees payable to the Consultant
hereunder, the Consultant hereby transfers and assigns to the Client all
intellectual property rights, arising during the term of this Agreement in and
to all ideas, know-how, discoveries, inventions, documents or other information
relating to the Technology as well as any copyright and other rights in any
designs, plans, specifications, documents or other work relating to the
Technology.

 

6.3                           The
Consultant agrees that any and all ideas, discoveries, inventions and
improvements (collectively, the “Inventions”)
which it may conceive or make during the term of this Agreement, either alone
or jointly with others, whether or not reduced to practice, relating or in any
way appertaining to or connected with the Technology shall be the sole and
exclusive property of the Client. The Consultant will, whenever so requested by
the Client, execute any and all applications, assignments, and other
instruments which the Client shall deem necessary in order to apply for and
obtain letters patent of Canada or foreign countries for said Inventions or for
any other reason, 

 

5

 

provided that the
Client pays all costs associated with preparing, reviewing and executing such
instruments, including for the reasonable time of the Consultant therefor.

 

6.4                           At all times during the term of this
Agreement, the Consultant will promptly disclose to the Client in writing and
in full and enabling detail, all Inventions it has conceived or created in
performance of the Advisory Services and relating to the Technology.

 

6.5                           The Consultant acknowledges and agrees
that all copyright and other rights in any designs, plans, specifications, documents
or other work (“Work”) it creates
in performance of the Advisory Services under this Agreement shall be the sole
and exclusive property of the Client. The Consultant hereby assigns all such
rights to the Client. The Consultant will, whenever so requested by the Client,
execute any and all applications, assignments, and other instruments which the
Client shall deem necessary in order to apply for and obtain registration of
copyright in any Work in Canada or foreign countries, provided that the Client pays
all costs associated with preparing, reviewing and executing such instruments,
including for the reasonable time of the Consultant therefor.

 

6.6                           The Consultant waives all moral rights or
author’s rights in any Work it may create during the term of this Agreement.

 

6.7                           The foregoing obligations shall continue
beyond the termination of this Agreement with respect to any and all Inventions
or Work conceived or made by the Consultant during the term hereof, assigns,
executors, administrators or other legal representatives.

 

ARTICLE 7 - MISCELLANEOUS

 

7.1                           Any notice
required to be given under this Agreement shall be in writing and shall be
sufficient if delivered by hand or sent by regular mail or post, postage pre-paid,
to:

 

(a)           In respect of the Client:  at the address specified above;

 

(b)           In respect of the Consultant: at the address
specified above;

 

and
shall be deemed to have been received four (4) business days after being sent
by registered mail, or, when delivered if such delivery is effected in person. The
addresses for notices may be changed from time to time by written notice given
by either party to the other in accordance with the provisions of this
Agreement.

 

7.2                           If for any
reason any term, covenant or provision of this Agreement or the application
thereof to any person or any circumstances is to any extent held or rendered
unenforceable or invalid, then such term, covenant or provision shall be and be
deemed to be independent in the remainder of this Agreement and shall be
severable and divisible therefrom and its unenforceability and invalidity shall
not affect, impair or invalidate the remainder of this Agreement or any part
thereof and such term, covenant or provision shall continue to be applicable to
and enforceable to the full extent permitted by law.

 

7.3                           No amendment or waiver of any provision
of this Agreement shall be binding on any party unless consented to in writing
by such party. No waiver of any provision of this Agreement shall constitute a
waiver of any other provision nor shall any waiver constitute a continuing
waiver unless otherwise provided.

 

6

 

7.4                           No
provision of this Agreement does or is intended to create a joint venture or
partnership or any similar relationship between the parties. The Consultant has
been engaged to perform certain work for the Client as an independent
contractor and not as an employee or agent of the Client and neither party is
authorized to incur any debt, liability or obligation for the other without the
other party’s express permission in writing. The Consultant expressly agrees
that it shall not represent that it is an officer or other agent of the Client
except as expressly authorized by the Client in writing. The Consultant shall
at its own expense, pay all income taxes, unemployment insurance premiums,
Canada Pension Plan premiums, Workers’ Compensation contributions, and all
other taxes, charges and contributions levied or required by competent
governmental authorities in Canada or the U.S. in respect of monies paid to the
Consultant under this Agreement and the Client will not have any obligation
whatsoever to compensate the Consultant or any Designee for annual vacation,
sickness, accident or disability, whether or not resulting from the performance
by the Consultant of obligations of the Consultant under this Agreement,
retirement pension or benefits or any benefits resulting from the expiration of
the Term of this Agreement or for any other benefits accorded by the Client to
any of its employees.

 

7.5                           This
Agreement sets forth all the promises, agreements, conditions, conditions
precedent, representations, warranties and understandings whether express or
implied between the parties hereto respecting the subject matter hereof and
there are no promises, agreements, conditions, conditions precedent,
representations, warranties or understandings other than as set forth herein
and supersedes all prior arrangements. No term or provision of this Agreement may be
amended, discharged or modified in any respect except in writing signed by the
parties hereto.

 

7.6                           The Consultant acknowledges that a breach
by the Consultant of any of the covenants contained in Articles 4 and 6 of this
Agreement shall result in damages to the Client and that the Client could not
be adequately compensated for such damages by a monetary award. Accordingly, in
the event of any such breach, in addition to all other remedies available to
the Client at law or in equity, the Client shall be entitled as a matter of
right to apply to a court of competent jurisdiction for such relief by way of
restraining order, temporary or permanent injunction, decree or otherwise, as
may be appropriate to ensure compliance with the provisions of this Agreement.

 

7.7                           Each of
the parties to this Agreement acknowledge that it has had independent legal
advice regarding the execution of this Agreement, or has been advised of its
respective right to obtain independent legal advice, and if it has not in fact
obtained independent legal advice, each party acknowledges herewith that it
understands the contents of this Agreement and that it is executing the same
voluntarily and without pressure from the other party or anyone on such other
party’s behalf.

 

7.8                           Neither
party shall assign this Agreement or its rights, duties or obligations
hereunder to any other party without the prior written approval of the other
parties hereto.

 

7.9                           This
Agreement shall be governed by and construed in accordance with the laws of the
Province of British Columbia and the federal laws of Canada applicable therein,
and the parties hereby irrevocably attorn to jurisdiction of the courts of the
Province of British Columbia in all matters.

 

7.10                         Time shall
be of the essence.

 

7.11                         The provisions of Articles 3, 4, 6, and 7
shall survive the termination of this Agreement.

 

7.12                         Any amount payable under this Agreement shall
be paid in American currency.

 

7

 

7.13                         The
Consultant represents and warrants that it is not a party to any agreement or
under any other obligation to other persons or entities, including any former
employer or client, nor does the Consultant have any interest which is
inconsistent with or in conflict with or which would prevent, limit or impair
the Consultant’s performance of any obligations hereunder. The Consultant acknowledges that the
Client is not requesting the Consultant disclose any confidential information
which the Consultant may have obtained from a former employer or client.

 

IN WITNESS
WHEREOF the parties hereto have executed this Agreement
this 15th day of March, 2005.

 

	
   

  	
  CANAID,
  Inc.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  /s/ Neil Clendeninn

  
	
   

  	
  Neil
  Clendeninn

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  OncoGeneX Technologies Inc.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  /s/ Scott Cormack

  
	
   

  	
  Scott
  Cormack, President and CEO

  

 

8

 

	
  Confidentiality &
  Privacy Policy

  	
   

  	
  

  

 

This policy outlines the
principles and commitments that OncoGenex Technologies Inc. (“OncoGenex”) makes
to its employees and consultants regarding the protection of their personal
information.

 

Definitions

 

“Personal Information” is
information about an identifiable individual and includes employee personal
information but does not include business contact information and work product
information, as defined below. In the case of employees and consultants,
Personal Information includes, but is not limited to, home postal and e-mail
addresses, home telephone number, social insurance number, income, educational
qualifications, disciplinary actions, and personal health information.

 

“Employee Personal Information”
is Personal Information about an individual that relates to establishing,
managing and terminating the employment relationship. It does not include
personal information that is not about an individual’s employment.

 

“Business Contact Information”
means information to enable an individual at a place of business to be
contacted (i.e. name, position, business telephone and fax numbers, business
postal and e-mail addresses).

 

“Work Product Information”
means information prepared or collected as part of an individual’s or group’s
responsibilities or activities related to the individual’s or group’s
employment or business activities.

 

Accountability

 

The overall responsibility for
the protection of Personal Information and compliance with this policy, the Personal Information Protection Act (the “Act”), and any other privacy legislation that may apply
from time to time, rests with OncoGenex’s Privacy Officer.

 

Purposes For Collection, Use
and Disclosure of Personal Information

 

The Personal Information of
OncoGenex’s employees and consultants will be collected, used and disclosed
during their employment or consultancy with OncoGenex for purposes related to
establishing, maintaining and terminating the employment or consulting
relationship, including:

 

•      Verifying employment or
consultancy eligibility

•      Maintaining accurate
personnel or consultancy records

•      Paying wages or fees

•      Administering benefits or
other contractual terms, and

•      Performance assessment

 

In addition, from time to time,
OncoGenex may require its employees and consultants to consent to the
disclosure of their Personal Information to current and/or potential investors.

 

Confidentiality
& Privacy Policy

Revised:
February 28, 2005

1

 

Collection, Use and Disclosure
of Personal Information

 

OncoGenex will obtain employee
and consultant consent to collect, use or disclose Personal Information for the
purposes set out above where such consent is required by the Act. If employee or consultant consent to collect, use or
disclose Personal Information is not required, employees or consultants may
receive notice of the purpose for the collection, use or disclosure of their
Personal Information prior to its collection, use or disclosure. However, there
are some circumstances under the Act where
Personal Information may be collected, used or disclosed without consent or
notice.

 

Personal information will only
be collected, used and disclosed for the purposes identified and will only be
disclosed to third parties where OncoGenex has the employee’s or consultant’s
consent to such disclosure (if consent is required), where the employee or
consultant is notified of the purpose of the disclosure, or where required or
permitted by law.

 

If consent is required to
collect, use or disclose Personal Information, employees and consultants have
the right to withdraw consent to the collection, use or disclosure of their
Personal Information at any time. However, there may be consequences to such
withdrawal. If an employee or consultant withdraws their consent, OncoGenex
will inform the employees or consultant of the likely consequences of such
action. An individual may not withdraw consent if withdrawing the consent would
frustrate the performance of a legal obligation.

 

Accuracy

 

OncoGenex will ensure that all
Personal Information it collects and stores shall be as accurate, complete and
up-to-date as required for the purpose for which it was collected.

 

Safeguarding Personal
Information

 

OncoGenex will implement security
practices to ensure that Personal Information is protected from unauthorized
access, collection, use, disclosure, copying, modification or disposal. Such
safeguards will be appropriate to the sensitivity of the information.

 

Retention of Personal Information

 

OncoGenex will retain Personal
Information only as long as is necessary to fulfill the purpose for which it
was collected, or a related business or legal purpose. OncoGenex will retain
Personal Information that is used to make a decision about an employee or
consultant for at least one year after using it so the employee or consultant
has a reasonable opportunity to obtain access to the information.

 

Rights of Access and Correction

 

Employees and consultants have
the right to access their Personal Information and request correction, if
necessary, of such information. An employee or consultant may access his/her
Personal Information or request correction of his/her Personal Information by
sending a written request to the Privacy Officer.

 

2

 

OncoGenex will provide the
employee or consultant with a reply to their request within thirty (30)
business days.

 

If, for any reason, the request
for access to, or correction of, Personal Information is refused, the employee
or consultant will be informed, in writing, of the reasons for refusal and the
provision of the Act on which the refusal is
based. The employee or consultant will also be provided with the contact
information of the personnel at OncoGenex who can answer questions about the
refusal.

 

If OncoGenex is satisfied on
reasonable grounds that a request for correction should be implemented, it will
correct the information as soon as reasonably possible and send the corrected
information to each organization to which the Personal Information was
disclosed during the year before the date the correction was made. If no
correction is made, OncoGenex will annotate the Personal Information with the
correction that was requested but not made.

 

Openness

 

OncoGenex is open about the
policies and procedures it uses to protect Personal Information. Employees and
consultants are to contact the Privacy Officer for further information
regarding OncoGenex’s policies and procedures.

 

Complaints

 

Employees and consultants are
to direct any complaints, concerns or questions regarding this policy, or
OncoGenex’s compliance with the Act, in writing
to the Privacy Officer:

 

Sherry
Tryssenaar, Chief Financial Officer

OncoGenex
Technologies Inc.

400- 1001 West
Broadway

Vancouver,
BC  V6H 4B1

 

All complaints received will be
investigated in a fair, impartial and confidential manner.

 

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]